-
Notifications
You must be signed in to change notification settings - Fork 81
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
Update 20.treatments.md #75
Conversation
Co-Authored-By: Anthony Gitter <agitter@users.noreply.github.com>
@dianerafi based on your intro in #17 , I was wondering if you would be able to give @aadattoli some feedback on this section? And @rishirajgoel I know you are already working on another section, but I wanted to tag you here as well in case you're interested in looking it over |
Yep. Happy to read it over! |
Sure! I'd be glad to look it over. |
@nilswellhausen I also wanted to tag you here and see if you have any thoughts, since you've been very involved in this section! |
I think it would be useful to incorporate the text blocks into #95 to fit them into the updated overall structure.
Interferon-beta: Avigan and Remdesivir: |
@nilswellhausen I added a bit of intro for the antivirals, see what you think. I'm not sure I am done with the intro of the antivirals, I might add more (please tell me if you have any suggestions). Once I feel I'm done I will Incorporate everything into #95. Btw, do you guys want me to be more specific in the mechanism of action of these drugs? |
@aadattoli we also have someone else adding some info on Remdesivir. Updated to say: it's in #111 , please feel free to add comments on that pull request! Once he submits his Pull Request, his section will also get feedback from others (hopefully you!) and we will integrate it with your content. I just wanted to keep you in the loop about other work being done on this section! |
@aadattoli we are planning to merge this in this morning, unless we hear from you in the next few hours. I made some changes based on the references I could find, but you are definitely welcome to make suggestions of additional papers that should be referenced (let's save it for the draft so we can get this merged in)! Thanks for your work on this! |
Co-Authored-By: Casey Greene <cgreene@users.noreply.github.com>
Co-Authored-By: Casey Greene <cgreene@users.noreply.github.com>
Co-Authored-By: Casey Greene <cgreene@users.noreply.github.com>
Co-Authored-By: Casey Greene <cgreene@users.noreply.github.com>
Co-Authored-By: HM Rando <halie.rando@pennmedicine.upenn.edu>
Co-Authored-By: HM Rando <halie.rando@pennmedicine.upenn.edu>
Co-Authored-By: HM Rando <halie.rando@pennmedicine.upenn.edu>
Co-Authored-By: HM Rando <halie.rando@pennmedicine.upenn.edu>
Co-Authored-By: HM Rando <halie.rando@pennmedicine.upenn.edu>
Dear All,
I edited the section about treatments and I added the tolicizumab drug analysis/description with relative literature. I am now working on the antiviral section. Please let me know your feedback.